Bessemer Group’s NantHealth, Inc NH Stock Holding History

Bessemer Group’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-900	Closed	-$45K	–	1915
2018 Q2	$45K	Buy	900 +700	+350%	+$34.6K	﹤0.01%	1255
2018 Q1	$9K	Buy	+200	New	+$10K	﹤0.01%	1499

Other funds holding NH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bessemer Group's NH Position: Q3 2018 in Review

Bessemer Group sold out of NantHealth, Inc (NH) in Q3 2018, closing a stake of 900 shares — an estimated $45K sold.

Bessemer Group first reported a position in NH in Q1 2018 and held it in 2 quarters. The position peaked at $45K in Q2 2018. 46 funds tracked by Wall St. Rank hold NH as of Q3 2018.

Bessemer Group reported no remaining NantHealth, Inc position as of Q3 2018 after selling out during the quarter.
Bessemer Group sold 900 NantHealth, Inc shares in Q3 2018, an estimated $45K.
Bessemer Group first reported a position in NantHealth, Inc in Q1 2018 and held it in 2 quarters.
Bessemer Group's NantHealth, Inc position peaked at $45K in Q2 2018.
46 funds tracked by Wall St. Rank held NantHealth, Inc as of Q3 2018.

Based on Bessemer Group's 13F filing for Q3 2018, filed 6 Nov 2018.